Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH announcement about website changes appears above the ClinicalTrials.gov 403 error page. The site revision also advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page components related to study documents and metadata (including the SAP note and several document entries) have been removed, reducing the amount of visible procedural and documentation information on the study record.SummaryDifference18%

- Check36 days agoChange DetectedThe revision history now shows version 3.7.0 in place of 3.6.6, reflecting a new page update.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page now shows revision v3.6.6, replacing v3.6.5. This update reflects a new site revision for the page, with no changes to study details or outcomes.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now indicates a new revision tag: v3.6.5, and the previous v3.6.4 tag has been removed. This reflects a routine platform update without changes to the study content or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.